Anatara Lifesciences Ltd (ASX:ANR)

Steven Lydeamore
CEO
Market Cap (AUD): 9.94M
Sector: Health Care
Last Trade (AUD): 0.14 +0 (+0%)
Tab Bar

1. About

Anatara Lifesciences Ltd (ASX:ANR) is developing and commercialising innovative, evidence-based solutions for gastrointestinal health. 

Anatara is focused on building a portfolio of human gastrointestinal health products, with lead product GaRP (Gastrointestinal ReProgramming) being a dietary supplement with a range of potential indications for the relief of gastrointestinal tract (GIT) symptoms and conditions.

2. Business model

3. Strategy

4. Markets

5. Competition

6. History

7. Team

8. Financials

9. Risk